scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1045231997 |
P356 | DOI | 10.1038/MP.2011.26 |
P8608 | Fatcat ID | release_5eyvz3ruuzg57dpcjwyx6krc6u |
P932 | PMC publication ID | 3121947 |
P698 | PubMed publication ID | 21483429 |
P5875 | ResearchGate publication ID | 51042194 |
P50 | author | Sandrine Thuret | Q23782729 |
Annamaria Cattaneo | Q37830437 | ||
Jack Price | Q52280420 | ||
P2093 | author name string | P A Zunszain | |
C M Pariante | |||
L A Carvalho | |||
M J Garabedian | |||
C Anacker | |||
P2860 | cites work | GADD45 induction of a G2/M cell cycle checkpoint | Q22009111 |
Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells | Q28119034 | ||
Adult brain neurogenesis and psychiatry: a novel theory of depression | Q28140495 | ||
Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions | Q28244933 | ||
Alterations in 5-HT1B receptor function by p11 in depression-like states | Q28290425 | ||
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment | Q28295248 | ||
Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters | Q28363795 | ||
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway | Q28776004 | ||
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis | Q29619093 | ||
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
Antidepressants increase neural progenitor cells in the human hippocampus | Q30482397 | ||
Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. | Q30493524 | ||
Environmental enrichment requires adult neurogenesis to facilitate the recovery from psychosocial stress | Q30497444 | ||
Antidepressants and Cdk inhibitors: releasing the brake on neurogenesis? | Q33887734 | ||
Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. | Q33940032 | ||
Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation | Q34256767 | ||
Role of neurotrophic factors in the etiology and treatment of mood disorders | Q34303344 | ||
Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms. | Q34315494 | ||
(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms | Q34570818 | ||
The HPA axis in major depression: classical theories and new developments | Q34803590 | ||
Modulation of glucocorticoid receptor function via phosphorylation. | Q35841877 | ||
The role of CREB in depression and antidepressant treatment | Q36386532 | ||
Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression | Q36442038 | ||
p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus | Q36446238 | ||
Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. | Q36994922 | ||
Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes | Q37235520 | ||
Glucocorticoid receptor phosphorylation differentially affects target gene expression | Q37302402 | ||
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. | Q37380865 | ||
Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation | Q37586962 | ||
The glucocorticoid receptor: pivot of depression and of antidepressant treatment? | Q37732806 | ||
Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex | Q38333918 | ||
Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. | Q39677789 | ||
Antidepressants increase β-arrestin 2 ubiquitinylation and degradation by the proteasomal pathway in C6 rat glioma cells | Q39765478 | ||
Time-dependent activation of Phox2a by the cyclic AMP pathway modulates onset and duration of p27Kip1 transcription | Q39831318 | ||
De-phosphorylation of GR at Ser203 in nuclei associates with GR nuclear translocation and GLUT5 gene expression in Caco-2 cells | Q39990483 | ||
Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. | Q40355189 | ||
Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (lipid rafts). | Q40455521 | ||
Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells | Q40661639 | ||
The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function | Q40685855 | ||
Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine | Q41088014 | ||
Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor | Q41520561 | ||
Modulation of glucocorticoid receptor function by protein kinase A. | Q41605052 | ||
Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters | Q41947488 | ||
The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice | Q42171425 | ||
Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment | Q42440623 | ||
Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors | Q42510862 | ||
Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants. | Q42682344 | ||
Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice | Q43130558 | ||
Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus | Q43640160 | ||
Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. | Q43890700 | ||
Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo | Q43986658 | ||
Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture | Q44430635 | ||
The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones | Q44464123 | ||
The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. | Q46266275 | ||
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal | Q46649293 | ||
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. | Q46767739 | ||
Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice | Q46802984 | ||
Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone | Q46834052 | ||
Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones | Q48091332 | ||
Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone | Q48164425 | ||
Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients | Q48317806 | ||
Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats | Q48363729 | ||
Effect of brief corticosterone administration on SGK1 and RGS4 mRNA expression in rat hippocampus. | Q48389435 | ||
Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior | Q48423697 | ||
Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor. | Q48428036 | ||
Modulation of adult hippocampal neurogenesis by thyroid hormones: implications in depressive-like behavior | Q48667457 | ||
Adult hippocampal neurogenesis is involved in anxiety-related behaviors | Q48718504 | ||
A morphogenetic wave of p27Kip1 transcription directs cell cycle exit during organ of Corti development. | Q52014319 | ||
Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase. | Q52585843 | ||
Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures | Q69705215 | ||
The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats | Q72684743 | ||
Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein | Q73182603 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurogenesis | Q1456827 |
P304 | page(s) | 738-750 | |
P577 | publication date | 2011-04-12 | |
P1433 | published in | Molecular Psychiatry | Q6895973 |
P1476 | title | Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor | |
P478 | volume | 16 |
Q104795073 | A distinct transcriptional signature of antidepressant response in hippocampal dentate gyrus granule cells |
Q47568306 | A parallel universe where psychiatry is like the rest of medicine |
Q27006797 | A systems approach to stress, stressors and resilience in humans |
Q37168099 | AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes |
Q39297161 | Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha |
Q35813129 | Acute and chronic stress differentially regulate cyclin-dependent kinase 5 in mouse brain: implications to glucocorticoid actions and major depression |
Q47609337 | Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis via Regulating the Sensitivity of Glucocorticoid Receptor. |
Q39281544 | Adult hippocampal neurogenesis and cognitive flexibility - linking memory and mood |
Q35182020 | Adult hippocampal neurogenesis buffers stress responses and depressive behaviour |
Q33634893 | Adult neuroplasticity: more than 40 years of research |
Q97692988 | Adult-born neurons from the dorsal, intermediate, and ventral regions of the longitudinal axis of the hippocampus exhibit differential sensitivity to glucocorticoids |
Q48843230 | Advances in depression research: 2011. |
Q27006549 | Age- and sex-dependent effects of early life stress on hippocampal neurogenesis |
Q34062101 | Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions |
Q99404602 | Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function |
Q35811453 | An Aminopropyl Carbazole Derivative Induces Neurogenesis by Increasing Final Cell Division in Neural Stem Cells |
Q35179051 | Antidepressant compounds can be both pro- and anti-inflammatory in human hippocampal cells |
Q41871229 | Antidepressant-like activity of 10-hydroxy-trans-2-decenoic Acid, a unique unsaturated Fatty Acid of royal jelly, in stress-inducible depression-like mouse model |
Q64065500 | Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior |
Q38152966 | Antidepressants for neuro-regeneration: from depression to Alzheimer's disease |
Q28395248 | Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy |
Q33898238 | Association between resting energy expenditure, psychopathology and HPA-axis in eating disorders |
Q92667458 | Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approach |
Q27320250 | Baicalin promotes hippocampal neurogenesis via SGK1- and FKBP5-mediated glucocorticoid receptor phosphorylation in a neuroendocrine mouse model of anxiety/depression |
Q48852410 | Can adult neurogenesis buffer stress responses and depressive behaviour? |
Q28391808 | Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? |
Q36539999 | Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. |
Q40548377 | Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? |
Q35986829 | Characterisation of neurons derived from a cortical human neural stem cell line CTX0E16 |
Q58775608 | Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression |
Q47750834 | Cognitive Performance and the Alteration of Neuroendocrine Hormones in Chronic Tension-Type Headache |
Q38645158 | Comparing the Effects of Melatonin with Caloric Restriction in the Hippocampus of Aging Mice: Involvement of Sirtuin1 and the FOXOs Pathway |
Q37641257 | Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms |
Q55348043 | Control of the Cell Cycle in Adult Neurogenesis and its Relation with Physical Exercise. |
Q34195801 | Coping and glucocorticoid receptor regulation by stress inoculation. |
Q38008032 | Cortisol and depression: three questions for psychiatry |
Q38587566 | Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders. |
Q38197366 | Depression during pregnancy: molecular regulations of mothers' and children's behaviour |
Q34577617 | Depression pathogenesis and treatment: what can we learn from blood mRNA expression? |
Q95319250 | Depression-an underrecognized target for prevention of dementia in Alzheimer's disease |
Q38560579 | Desipramine treatment has minimal effects on the brain accumulation of glucocorticoids in P-gp-deficient and wild-type mice |
Q30455078 | Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients |
Q47667621 | Differences in Active Avoidance Conditioning in Male and Female Rats with Experimental Anxiety-Depressive Disorder. |
Q89963863 | Differential Phosphorylation of the Glucocorticoid Receptor in Hippocampal Subregions Induced by Contextual Fear Conditioning Training |
Q36334155 | Dynamic glucocorticoid-dependent regulation of Sgk1 expression in oligodendrocytes of adult male rat brain by acute stress and time of day. |
Q58549216 | Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review |
Q39143491 | Effect of sertraline on proliferation and neurogenic differentiation of human adipose-derived stem cells |
Q48063429 | Efficiency of Umbilical Cord Blood Cells in Patients with Treatment-Resistant Depressions. |
Q57189805 | Emotion regulation mediates the relationship between verbal learning and internalizing, trauma-related and externalizing symptoms among early-onset, persistently delinquent adolescents |
Q64941082 | Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB-driven inflammation and cardiovascular risk. |
Q38693272 | Epigenetics/Programming in the HPA Axis |
Q59329405 | Examination of Current Treatments and Symptom Management Strategies Used by Patients With Mal De Debarquement Syndrome |
Q35224304 | Fluoxetine regulates neurogenesis in vitro through modulation of GSK-3β/β-catenin signaling |
Q30588606 | Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism |
Q38192667 | Fresh approaches to antidepressant drug discovery |
Q37951354 | From stress to postpartum mood and anxiety disorders: how chronic peripartum stress can impair maternal adaptations. |
Q36366772 | Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications |
Q38161940 | Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism |
Q53502157 | Genome-wide association study of treatment response to venlafaxine XR in generalized anxiety disorder. |
Q50693409 | Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents. |
Q36610037 | Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment |
Q36901174 | Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis |
Q35592683 | High dimensional endophenotype ranking in the search for major depression risk genes |
Q33705029 | Impaired Spinal Glucocorticoid Receptor Signaling Contributes to the Attenuating Effect of Depression on Mechanical Allodynia and Thermal Hyperalgesia in Rats with Neuropathic Pain |
Q37978784 | Increased expression of the anti-apoptotic protein Bcl-xL in the brain is associated with resilience to stress-induced depression-like behavior |
Q92364375 | Increasing Adiponergic System Activity as a Potential Treatment for Depressive Disorders |
Q30430203 | Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood. |
Q28909841 | Integrated proteomics identified novel activation of dynein IC2-GR-COX-1 signaling in neurofibromatosis type I (NF1) disease model cells |
Q46083495 | Inter-individual variation in genes governing human hippocampal progenitor differentiation in vitro is associated with hippocampal volume in adulthood |
Q47609660 | Interferon-Alpha Reduces Human Hippocampal Neurogenesis and Increases Apoptosis via Activation of Distinct STAT1-Dependent Mechanisms. |
Q39445647 | Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis |
Q42326811 | Investigating schizophrenia in a "dish": possibilities, potential and limitations |
Q37969149 | Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review |
Q37330681 | Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties |
Q42511821 | Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior |
Q28543597 | Kuwanon V inhibits proliferation, promotes cell survival and increases neurogenesis of neural stem cells |
Q91523045 | Lifestyle mediates the role of nutrient-sensing pathways in cognitive aging: cellular and epidemiological evidence |
Q33949107 | Mechanisms for interferon-α-induced depression and neural stem cell dysfunction. |
Q42694394 | Modulation of Adult Hippocampal Neurogenesis by Sleep: Impact on Mental Health |
Q38384189 | Molecular mechanisms in the regulation of adult neurogenesis during stress. |
Q35167271 | Neural stem cells respond to stress hormones: distinguishing beneficial from detrimental stress |
Q37260128 | Neurobiology of major depressive disorder |
Q37981491 | Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments |
Q36451816 | Neuronal correlates of depression. |
Q34381499 | Neuroplasticity and major depression, the role of modern antidepressant drugs |
Q35761683 | New Neurons in Aging Brains: Molecular Control by Small Non-Coding RNAs |
Q42435232 | New models to investigate complex glucocorticoid receptor functions |
Q43079460 | Novel antidepressant-like activity of propolis extract mediated by enhanced glucocorticoid receptor function in the hippocampus |
Q39389805 | Nuclear receptors in neural stem/progenitor cell homeostasis. |
Q38029587 | Nutrition, adult hippocampal neurogenesis and mental health |
Q48224057 | Paroxetine up-regulates neurogenesis in hippocampus-derived neural stem cell from fetal rats |
Q45327750 | Patterns and predictors of treatment outcome for antenatal major depression. |
Q26742185 | Protein Kinase A and Anxiety-Related Behaviors: A Mini-Review |
Q26800960 | Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy? |
Q45276014 | Region-dependent and stage-specific effects of stress, environmental enrichment, and antidepressant treatment on hippocampal neurogenesis |
Q35679944 | Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression |
Q38681297 | Rescue of IL-1β-induced reduction of human neurogenesis by omega-3 fatty acids and antidepressants |
Q92799365 | Revealing Antidepressant Mechanisms of Baicalin in Hypothalamus Through Systems Approaches in Corticosterone- Induced Depressed Mice |
Q34343309 | Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis |
Q47777006 | Saikosaponin D relieves unpredictable chronic mild stress induced depressive-like behavior in rats: involvement of HPA axis and hippocampal neurogenesis. |
Q39213199 | Sertraline increases the survival of retinoic acid induced neuronal cells but not glial cells from human mesenchymal stem cells. |
Q38779220 | Sex hormones and adult hippocampal neurogenesis: Regulation, implications, and potential mechanisms. |
Q38119012 | Sex, hormones and neurogenesis in the hippocampus: hormonal modulation of neurogenesis and potential functional implications |
Q42038314 | Stem cells in drug screening for neurodegenerative disease |
Q47701041 | Strain Differences and Effects of Environmental Manipulation on Astrocytes (Glial Fibrillary Acidic Protein), Glucocorticoid Receptor, and Microglia (Iba1) Immunoreactivity between Wistar-Kyoto and Wistar Females |
Q35161429 | Stress inoculation modeled in mice |
Q38658765 | Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway. |
Q26782877 | Stress, glucocorticoid hormones, and hippocampal neural progenitor cells: implications to mood disorders |
Q38187548 | Stress, glucocorticoid receptors, and adult neurogenesis: a balance between excitation and inhibition? |
Q27013911 | Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy |
Q35900185 | Stress-Induced Anxiety- and Depressive-Like Phenotype Associated with Transient Reduction in Neurogenesis in Adult Nestin-CreERT2/Diphtheria Toxin Fragment A Transgenic Mice |
Q38016982 | Stress-related depression: neuroendocrine, genetic, and therapeutical aspects |
Q46789230 | Stressing new neurons into depression? |
Q64249357 | Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk |
Q94464760 | Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges |
Q35747650 | The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial |
Q42578830 | The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review |
Q33902992 | The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro |
Q34943860 | The current state of the neurogenic theory of depression and anxiety |
Q38783826 | The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels. |
Q35969352 | The genetic and epigenetic journey of embryonic stem cells into mature neural cells. |
Q33835818 | The genome-wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response |
Q38004705 | The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications |
Q88427169 | The role of adult hippocampal neurogenesis in brain health and disease |
Q92810474 | The role of circulatory systemic environment in predicting interferon-alpha-induced depression: The neurogenic process as a potential mechanism |
Q36090823 | The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety |
Q38103493 | The role of inflammatory cytokines on the aetiopathogenesis of depression |
Q97418088 | The role of omega-3 fatty acids in preventing glucocorticoid-induced reduction in human hippocampal neurogenesis and increase in apoptosis |
Q33817003 | The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test |
Q36283104 | Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning |
Q94550992 | Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depression |
Q34831324 | Transient domoic acid excitotoxicity increases BDNF expression and activates both MEK- and PKA-dependent neurogenesis in organotypic hippocampal slices |
Q38843741 | Treatment Options for Individuals with PTSD and Concurrent TBI: A Literature Review and Case Presentation |
Q36024880 | Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise. |
Q52686429 | What is mood? A computational perspective. |
Q48452944 | p27kip1 Is Required for Functionally Relevant Adult Hippocampal Neurogenesis in Mice |
Search more.